Filing Details

Accession Number:
0001104659-24-005661
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-01-22 20:38:06
Reporting Period:
2024-01-19
Accepted Time:
2024-01-22 20:38:06
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
925741 Biocardia Inc. BCDA () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
898860 Al Et Md Phillip Frost 4400 Biscayne Blvd.
Miami FL 33137
No No Yes No
1380896 Trust Investments Gamma Frost 4400 Biscayne Blvd.
Miami FL 33137
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2024-01-19 129,802 $0.43 1,896,025 No 4 S Indirect See footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect See footnote
Footnotes
  1. This transaction was executed in multiple trades at prices ranging from $0.38 to $0.57, inclusive. The price reported above reflects the weighted average sale price.
  2. On June 6, 2019, the Issuer effected a 1-9 reverse stock split of its common stock (the "Reverse Stock Split"). The amount of securities reported on this Form 4 have been adjusted to reflect the Reverse Stock Split.
  3. These securities are held by Frost Gamma Investments Trust, of which the Reporting Person is the trustee. Frost Gamma Limited Partnership is the sole and exclusive beneficiary of Frost Gamma Investments Trust. The Reporting Person is one of two limited partners of Frost Gamma Limited Partnership. The general partner of Frost Gamma Limited Partnership is Frost Gamma, Inc., and the sole shareholder of Frost Gamma, Inc. is Frost-Nevada Corporation, of which the Reporting Person is the sole shareholder.